Beer and bread to brains and beyond: can yeast cells teach us about neurodegenerative disease? - PubMed (original) (raw)
Review
doi: 10.1159/000109759. Epub 2007 Dec 5.
Affiliations
- PMID: 18097160
- DOI: 10.1159/000109759
Review
Beer and bread to brains and beyond: can yeast cells teach us about neurodegenerative disease?
Aaron D Gitler. Neurosignals. 2008.
Abstract
For millennia, humans have harnessed the astonishing power of yeast, producing such culinary masterpieces as bread, beer and wine. Therefore, in this new millennium, is it very farfetched to ask if we can also use yeast to unlock some of the modern day mysteries of human disease? Remarkably, these seemingly simple cells possess most of the same basic cellular machinery as the neurons in the brain. We and others have been using the baker's yeast, Saccharomyces cerevisiae, as a model system to study the mechanisms of devastating neurodegenerative diseases such as Parkinson's, Huntington's, Alzheimer's and amyotrophic lateral sclerosis. While very different in their pathophysiology, they are collectively referred to as protein-misfolding disorders because of the presence of misfolded and aggregated forms of various proteins in the brains of affected individuals. Using yeast genetics and the latest high-throughput screening technologies, we have identified some of the potential causes underpinning these disorders and discovered conserved genes that have proven effective in preventing neuron loss in animal models. Thus, these genes represent new potential drug targets. In this review, I highlight recent work investigating mechanisms of cellular toxicity in a yeast Parkinson's disease model and discuss how similar approaches are being applied to additional neurodegenerative diseases.
Similar articles
- Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
Outeiro TF, Giorgini F. Outeiro TF, et al. Biotechnol J. 2006 Mar;1(3):258-69. doi: 10.1002/biot.200500043. Biotechnol J. 2006. PMID: 16897706 Review. - Yeast unfolds the road map toward alpha-synuclein-induced cell death.
Franssens V, Boelen E, Anandhakumar J, Vanhelmont T, Büttner S, Winderickx J. Franssens V, et al. Cell Death Differ. 2010 May;17(5):746-53. doi: 10.1038/cdd.2009.203. Epub 2009 Dec 18. Cell Death Differ. 2010. PMID: 20019751 Review. - [Neurodegenerative conformational disease and its molecular bases].
Li WW, Cai DF, Ren HM. Li WW, et al. Sheng Li Ke Xue Jin Zhan. 2006 Apr;37(2):97-102. Sheng Li Ke Xue Jin Zhan. 2006. PMID: 16850610 Review. Chinese. - Simple is good: yeast models of neurodegeneration.
Tenreiro S, Outeiro TF. Tenreiro S, et al. FEMS Yeast Res. 2010 Dec;10(8):970-9. doi: 10.1111/j.1567-1364.2010.00649.x. FEMS Yeast Res. 2010. PMID: 20579105 Review. - Protein-misfolding diseases and chaperone-based therapeutic approaches.
Chaudhuri TK, Paul S. Chaudhuri TK, et al. FEBS J. 2006 Apr;273(7):1331-49. doi: 10.1111/j.1742-4658.2006.05181.x. FEBS J. 2006. PMID: 16689923 Review.
Cited by
- Reversing deleterious protein aggregation with re-engineered protein disaggregases.
Jackrel ME, Shorter J. Jackrel ME, et al. Cell Cycle. 2014;13(9):1379-83. doi: 10.4161/cc.28709. Epub 2014 Apr 2. Cell Cycle. 2014. PMID: 24694655 Free PMC article. - Polyglutamine misfolding in yeast: toxic and protective aggregation.
Duennwald ML. Duennwald ML. Prion. 2011 Oct-Dec;5(4):285-90. doi: 10.4161/pri.18071. Epub 2011 Oct 1. Prion. 2011. PMID: 22052348 Free PMC article. Review. - Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins.
Braun RJ. Braun RJ. Front Mol Neurosci. 2015 Mar 12;8:8. doi: 10.3389/fnmol.2015.00008. eCollection 2015. Front Mol Neurosci. 2015. PMID: 25814926 Free PMC article. Review. - Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.
Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, Shorter J, Gitler AD. Sun Z, et al. PLoS Biol. 2011 Apr;9(4):e1000614. doi: 10.1371/journal.pbio.1000614. Epub 2011 Apr 26. PLoS Biol. 2011. PMID: 21541367 Free PMC article. - RNA-binding proteins with prion-like domains in ALS and FTLD-U.
Gitler AD, Shorter J. Gitler AD, et al. Prion. 2011 Jul-Sep;5(3):179-87. doi: 10.4161/pri.5.3.17230. Epub 2011 Jul 1. Prion. 2011. PMID: 21847013 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases